跳至主要内容
临床试验/IRCT20141209020258N137
IRCT20141209020258N137已完成2 期

A study comparing the effectiveness of pomegranate versus Gabapentin for treatment of Diabetic nephropathy in patients of diabetus melitus type 2

Arak University of Medical Sciences0 个研究点目标入组 74 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Patients with type 2 diabetes who have painful lower extremity nephropathy for at least 3 months
  • Age between 70 and 30 years
  • Do not take pomegranate pills.
  • Do not have severe physical, neurological or psychiatric illness.
  • Do not become pregnant or breast-feeding.

排除标准

  • Severe sensitivity to pomegranate pills
  • Severe grade 4 heart failure or unstable angina
  • HbA1c greater than or equal to 8.5

研究者

相似试验